ClinicalTrials.gg
RecruitingNCT06016426Updated Aug 29, 2023

Mass Closure vs Layer by Layer Closure

An interventional study of Mass closure vs layer by layer closure of transverse laparotomy incisions in children and infants. in Abdominal Wall Wound, Ventral Hernia and Incisional Hernia, sponsored by Tanta University. Recruiting at 1 site in Egypt. Open to participants aged 3 Months to 1 Year. Per ClinicalTrials.gov, last updated 2023-08-29.

Sponsored by Tanta University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Oct 2024, 2 years ago, but the record still lists the study as recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
3 Months to 1 Year
Sex
All
01

Study summary

to assess two different ways of closure of laparotomy in children and infants

Read the detailed description

Introduction:

The technique of abdominal wall closure in infants subjected to abdominal transverse laparotomy incision may have an impact not only on the development of a future incisional hernia but also on the function of the anterior abdominal wall muscles.

There are two ways to close this laparotomy incision. These ways are either closure in mass or layer by layer closure. Neither of them is superior to the other.

The main issue that minds the pediatric surgeons is a safe and successful repair of the abdominal wall incision and the avoidance of the development of incisional hernia.

The aim of this work is to randomly compare the two different techniques of the closure of transverse laparotomy incision.

Patients and methods:

  • Study design: The study was performed during the period from January 2020 to October 2024. It is a randomized control trial.

Inclusion criteria were infants younger than 3 years. We excluded infants with history of prematurity, previous abdominal operations and infants with congenital abdominal wall defects.

An informed consent was obtained from the parents or the care giver of every participant.

Randomization was obtained using closed envelop method. Patients were categorized into two groups A and B. Group A included patients that their exploratory wound was closed with mass closure method using Vicryl® 2/0 round needle. Group B included patients that their exploratory wound was closed layer by layer using the same suture material.

In both groups the ratio of the suture length to the wound was 3 to 1. - The measured variables: The variables that were addressed were

  1. the mean operative time in minutes,
  2. the incidence of wound dehiscence,
  3. the occurrence of wound infection,
  4. The development of an incisional hernia
  5. Long term assessment of both abdominal wall structure and dynamics of abdominal muscles at the site of incision.

    • Follow up protocol:

All patients were scheduled on a follow up regimen. They were examined weekly for one month post-operative. Then monthly for one year. The anterior abdominal wall of these patients was examined by ultrasound at the 6th and 12th moth postoperatively. This helped assessment of the dynamics and structure of the muscles at the site of the incision.

  • Statistical analysis: Statistical analysis was conducted using SPSS ™ statistical package ver. 21 (IBM SPSS, NY, USA). Numerical data were compared using an independent sample t-test, whereas categorical data were compared using the chi-square test. Statistical significance was set at p \<0.05.
02

Conditions studied

  • Abdominal Wall Wound
  • Ventral Hernia
  • Incisional Hernia

Keywords

  • transverse laparotomy
  • incisional hernia
  • mass closure
  • layer by layer closure
03

In context

Hernia, Ventral

230 studies on the registry are indexed under Hernia, Ventral; 45 are open to participants now.

This study's planned enrollment of 50 is below the median of 90 across 153 interventional studies indexed under Hernia, Ventral.

Browse Hernia, Ventral studies →

Lead sponsor

Tanta University is the lead sponsor of 1,010 studies on the registry; 321 are open to participants now.

Of its 15 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Months to 1 Year
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • all infants and children with transverse laparotomy

Exclusion criteria

Exclusion Criteria:

  • previous abdominal operations
  • children and infants with congenital abdominal wall defects
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    mass closure

    infants and children whose transverse laparotomy incisions will be closed in mass closure.

    Other: Mass closure vs layer by layer closure of transverse laparotomy incisions in children and infants.

  • Active comparator
    layer by layer closure

    infants and children whose transverse laparotomy incisions will be closed layer by layer.

    Other: Mass closure vs layer by layer closure of transverse laparotomy incisions in children and infants.

Interventions

  • OtherMass closure vs layer by layer closure of transverse laparotomy incisions in children and infants.

    the transverse laparotomy incision in infants and children will be either closed as single layer included the peritoneum, posterior rectus sheath and anterior rectus sheath wit muscle sparing, or the laparotomy will be closed in layer by layer in which the peritoneum and posterior rectus sheath are closed as a layer and the anterior rectus sheath is closed as a seprate layer.

06

What researchers measure

Primary outcomes

  1. wound failure with the development of incisional hernia later in either group

    the occurrence or development of the incisional hernia is the primary outcome. the incidence of the development of this hernia will be recorded in each group. this will help choose the more appropriate method of transverse laparotomy closure in infants and children

    Time frame: one year

Secondary outcomes

  1. surgical site infections

    the number of patients who will develop a surgical site infections in each group, the mean duration of hospital stay if this happened. the number of patients who will later develop an incisional hernia

    Time frame: two weeks up to one month

07

Study locations

1 of 1 sites recruiting
  • Tanta University Hospitals
    Tanta, Gharbia 31111, Egypt
    Recruiting
    • Nagi E eldessouki, professor · Contact"nagi2709Staff" <neldesoky@med.tanta.edu.eg> · +20 201003546853
    • Suzan E Gado, professor · Principal investigator
    • Nagi E ldessouki, professor · Principal investigator
    • Radwa M Elkholy, professor · Principal investigator
    • Mazen O Kurdi, professor · Principal investigator
    • Ahmed Moukhtar, specalist · Sub investigator
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 29, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06016426
Lead sponsor
Tanta University
Responsible party
Mohammad Gharieb Mohammad Khirallah (professor of pediatric surgery, Tanta University) — Principal investigator
First posted
Aug 29, 2023
Start date
Sep 30, 2023 (estimated)
Primary completion
Oct 31, 2024 (estimated)
Completion
Nov 30, 2024 (estimated)
Last update
Aug 29, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion